Roger D. Stone

916 total citations
19 papers, 717 citations indexed

About

Roger D. Stone is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Roger D. Stone has authored 19 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 6 papers in Rheumatology and 5 papers in Neurology. Recurrent topics in Roger D. Stone's work include Multiple Sclerosis Research Studies (12 papers), Neurogenesis and neuroplasticity mechanisms (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Roger D. Stone is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Neurogenesis and neuroplasticity mechanisms (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Roger D. Stone collaborates with scholars based in United States and Italy. Roger D. Stone's co-authors include Henry F. McFarland, Nancy Richert, Roland Martinꝉ, T. Howard, Colin D. Shea, Bibiana Bielekova, C. Bash, Daniel S. Reich, Kaylan Fenton and Luca Massacesi and has published in prestigious journals such as The Journal of Immunology, Neurology and Annals of Neurology.

In The Last Decade

Roger D. Stone

18 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger D. Stone United States 13 397 204 150 134 124 19 717
Nicholas Sanderson United States 18 294 0.7× 386 1.9× 186 1.2× 190 1.4× 100 0.8× 30 915
Thierry Vincent France 17 375 0.9× 263 1.3× 335 2.2× 294 2.2× 156 1.3× 48 979
B. Kitze Germany 10 467 1.2× 607 3.0× 141 0.9× 110 0.8× 136 1.1× 19 990
Christine Ewing Australia 7 252 0.6× 574 2.8× 158 1.1× 44 0.3× 113 0.9× 8 883
Nicole Heijmans Netherlands 14 329 0.8× 323 1.6× 89 0.6× 77 0.6× 121 1.0× 18 641
M P Burgoon United States 12 266 0.7× 238 1.2× 347 2.3× 80 0.6× 65 0.5× 13 948
James B. Burns United States 17 179 0.5× 466 2.3× 123 0.8× 176 1.3× 52 0.4× 40 871
Holger Babbe Germany 8 616 1.6× 707 3.5× 253 1.7× 150 1.1× 122 1.0× 8 1.3k
B. G. Weinshenker United States 10 722 1.8× 225 1.1× 187 1.2× 586 4.4× 233 1.9× 17 1.1k
Bert ’t Hart Netherlands 11 168 0.4× 254 1.2× 222 1.5× 24 0.2× 115 0.9× 15 641

Countries citing papers authored by Roger D. Stone

Since Specialization
Citations

This map shows the geographic impact of Roger D. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger D. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger D. Stone more than expected).

Fields of papers citing papers by Roger D. Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger D. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger D. Stone. The network helps show where Roger D. Stone may publish in the future.

Co-authorship network of co-authors of Roger D. Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Roger D. Stone. A scholar is included among the top collaborators of Roger D. Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger D. Stone. Roger D. Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Stone, Roger D.. (2017). The Lives of Dillon Ripley.
2.
Shea, Colin D., Joan Ohayon, Blake C. Jones, et al.. (2012). The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 2(2). 133–140. 25 indexed citations
3.
Gaitán, María I., Colin D. Shea, Iordanis E. Evangelou, et al.. (2011). Evolution of the blood–brain barrier in newly forming multiple sclerosis lesions. Annals of Neurology. 70(1). 22–29. 127 indexed citations
4.
Regenold, William T., Pornima Phatak, Michael J. Makley, Roger D. Stone, & Mitchel A. Kling. (2008). Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression. Journal of the Neurological Sciences. 275(1-2). 106–112. 81 indexed citations
5.
Richert, Nancy, T. Howard, Joseph A. Frank, et al.. (2006). Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis. Neurology. 66(4). 551–556. 26 indexed citations
6.
Bagnato, Francesca, John A. Butman, Carlos A. Mora, et al.. (2005). Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. Journal of NeuroVirology. 11(6). 525–534. 34 indexed citations
7.
Bagnato, Francesca, Nancy Richert, Roger D. Stone, et al.. (2005). Effects of Interferon Beta-1b on Black Holes in Multiple Sclerosis Over a 6-Year Period With Monthly Evaluations. Archives of Neurology. 62(11). 1684–1684. 19 indexed citations
8.
Gupta, Sanjay, Jeffrey Solomon, Mengqiu Cao, et al.. (2005). Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis. Multiple Sclerosis Journal. 11(6). 658–668. 10 indexed citations
9.
Morgen, Katrin, Roger D. Stone, Roland Martinꝉ, et al.. (2005). Contrast-enhanced MRI lesions during treatment with interferonβ-1b predict increase in T1 black hole volume in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 11(2). 146–148. 7 indexed citations
10.
Frank, Joseph A., Nancy Richert, C. Bash, et al.. (2004). Interferon-β-1b slows progression of atrophy in RRMS. Neurology. 62(5). 719–725. 65 indexed citations
11.
Frank, J A, Nancy Richert, Bobbi K. Lewis, et al.. (2002). A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients. Multiple Sclerosis Journal. 8(1). 24–29. 74 indexed citations
12.
Richert, Nancy, Bobbi K. Lewis, C. Bash, et al.. (2002). A pilot study of recombinant insulin-like growth factor-I in seven multiple sclerosis patients. Multiple Sclerosis Journal. 8(1_suppl). 24–29. 2 indexed citations
13.
Morgen, Katrin, Neal Jeffries, Roger D. Stone, et al.. (2001). Ring-enhancement in multiple sclerosis: marker of disease severity. Multiple Sclerosis Journal. 7(3). 167–167. 32 indexed citations
14.
Morgen, Katrin, Roland Martinꝉ, Roger D. Stone, et al.. (2001). FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome. Neurology. 57(11). 1980–1985. 33 indexed citations
15.
Voskuhl, Rhonda R., Dale E. McFarlin, Roger D. Stone, & Henry F. McFarland. (1993). T-lymphocyte recognition of a portion of myelin basic protein encoded by an exon expressed during myelination. Journal of Neuroimmunology. 42(2). 187–191. 20 indexed citations
16.
Voskuhl, Rhonda R., Dale E. McFarlin, Laura R. Tranquill, et al.. (1993). A novel candidate autoantigen in a multiplex family with multiple sclerosis: prevalence of T-lymphocytes specific for an MBP epitope unique to myelination. Journal of Neuroimmunology. 46(1-2). 137–144. 22 indexed citations
17.
Martinꝉ, Roland, Ursula Utz, J E Coligan, et al.. (1992). Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. The Journal of Immunology. 148(5). 1359–1366. 130 indexed citations
18.
Stone, Roger D., et al.. (1992). New Mission for Foreign Aid. Foreign Affairs. 72(1). 196–196. 8 indexed citations
19.
Stone, Roger D. & James L. Vaughn. (1986). The effect of pH indicators chlorphenol red and bromocresol purple on the in vitro production of lepidopteran nuclear polyhedrosis viruses. Journal of Invertebrate Pathology. 48(3). 381–383. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026